Statistical analysis plan for the LAKANA trial: a cluster-randomized, placebo-controlled, double-blinded, parallel group, three-arm clinical trial testing the effects of mass drug administration of azithromycin on mortality and other outcomes among 1-11-month-old infants in Mali.

Juho LuomaLaura AdubraDagmar AlberPer AshornUlla AshornElaine Cloutman-GreenFatoumata DialloCamilla DuckerRiku ElovainioYue-Mei FanLily GatesGwydion GruffuddTiia HaapaniemiFadima HaidaraLotta HallamaaRikhard IhamuotilaNigel KleinOwen MartellSamba SowTaru VehmastoYin Bun Cheung

Published in: Trials (2023)

ClinicalTrials.gov ID NCT04424511 . Registered on 11 June 2020.

Keyphrases

drug administration
placebo controlled
phase iii
double blind
phase ii
clinical trial
study protocol
open label
cardiovascular events
phase ii study
risk factors
randomized controlled trial
coronary artery disease
radiation therapy